ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals Inc (SUPN)

36.22
0.40
(1.12%)
Closed November 24 3:00PM
36.22
0.00
(0.00%)
After Hours: 3:25PM

Supernus Pharmaceuticals Inc Financial Summary

The current SUPN market cap is 2B. The company's latest EPS is USD 0.0238 and P/E is 1521.85.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 154.34M164.52M144.74M172.68M176.71M
Operating Income 8.14M-996k-3.15M22.57M40.85M
Net Income -15.98M1.18M124k19.92M38.5M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 392.76M520.4M586.31M667.75M609.04M
Operating Income 148.57M173.7M86.03M46.12M-5.27M
Net Income 113.06M126.95M53.42M60.71M1.32M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 1.29B1.28B1.3B1.32B1.34B
Total Liabilities 372.97M356.16M374.92M358.38M335.55M
Total Equity 912.19M921.52M929.17M957.45M1.01B
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 1.16B1.5B1.69B1.7B1.28B
Total Liabilities 564.85M759.24M873.3M816.3M356.16M
Total Equity 595.43M744.86M815.85M886.2M921.52M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating 66.13M111.09M38.4M74.03M127.55M
Investing 334.71M268.73M-51.62M-100.22M-177.23M
Financing -398.97M-397.88M1.57M3.23M6.3M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating 143.13M138.4M127.13M116.83M111.09M
Investing -157.92M-34.7M-81.91M-216.66M268.73M
Financing 3.93M3.56M-130.42M-10.48M-397.88M
Market Cap 2B
Price to Earnings Ratio 1521.85
Price to Sales Ratio 3.28
Price to Cash Ratio 26.65
Price to Book Ratio 2.17
Dividend Yield -

Share Statistics

Shares Outstanding 55.22M
Average Volume (1 week) 254.95k
Average Volume (1 Month) 421.85k
52 Week Change 31.57%
52 Week High 39.37
52 Week Low 25.53
Spread (Intraday) 16.2 (32.73%)

Company Info

Company Name Supernus Pharmaceuticals Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.supernus.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock